Insights on Technology and Innovation

The Nanosys IPO already has owners of investing web sites salivating, and has generated such a torrent of ill informed […]

I recently spent a fascinating few days as part of a European Commission group looking at the future of medical

Nanosys finally filed for an IPO, which explain Merrill Lynchs unseemly haste to jump on the bandwagon. A $115 million

A press release entitled ” Nanotechnology helps to save water in Australia ” caught our attention, not least because of

A report in the Peoples Daily gets the wrong end of the rather greasy stick when it comes to defining

When it’s a nanoliter – or about this much. Our memories of the confusion between nanofluidics and nanotechnology were jogged

Hot on the heels of the Elan and Roche deal comes one between Dow Pharma and Bristol-Myers Squibb (which curiously

One of the reasons we got into the conference business was our dissatisfaction with the standard scientific conferences. From EuroFE

One of the major problems with drugs is getting them into the body in the first place. With the human

With the recent Royal Society survey showing an overwhelming lack of knowledge (and probably accompanying lack of interest) in nanotechnology